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Newcastle disease virus (NDV) entry into host cells is mediated by the hemagglutinin-neuraminidase (HN)
and fusion (F) glycoproteins. We previously showed that production of free thiols in F protein is required for
membrane fusion directed by F protein (S. Jain et al., J. Virol. 81:2328–2339, 2007). In the present study we
evaluated the oxidation state of F protein in virions and virus-like particles and its relationship to activation
of F protein by HN protein, F protein conformational intermediates, and virus-cell fusion. F protein, in
particles, does not have free thiols, but free thiols were produced upon binding of particles to target cells. Free
thiols were produced at 16°C in F protein in virions bound to the target cells. They also appeared in different
fusion defective mutant F proteins. Free thiols were produced in the presence of mutant HN proteins that are
defective in F protein activation but are attachment competent. These results suggest that free thiols appear
prior to any of the proposed major conformational changes in F protein which accompany fusion activation.
These results also indicate that HN protein binding to its receptor likely facilitates the interaction between F
protein and host cell isomerases, leading to reduction of disulfide bonds in F protein. Taken together, these
results show that free thiols are produced in F protein at a very early stage during the onset of fusion and that
the production of free thiols is required for fusion in addition to activation by HN protein.
Newcastle disease virus (NDV), an avian paramyxovirus,
enters the host cell by fusion of the viral membrane to the
plasma membrane. Two virion-associated glycoproteins, the
hemagglutinin-neuraminidase (HN) and fusion (F) proteins,
are responsible for virion attachment to the target cell receptor
and fusion of viral and host cell membranes, respectively. F
protein, a trimer, is synthesized as a precursor, F0, which is
cleaved into two disulfide linked subunits F1 and F2 (as re-
viewed in references 8, 21, and 32). The new amino terminus,
generated by cleavage of the precursor, is the fusion peptide
(FP). The fusion protein also contains two important heptad
repeat (HR) domains (reviewed in reference 7). One HR do-
main (HR1 or HRA) is located just carboxyl terminal to the
fusion peptide, and another (HR2 or HRB) is located adjacent
to transmembrane (TM) domain. HR1 and HR2 peptides have
strong affinity and form a very stable six helical bundle (6HB)
(4). Based on studies showing inhibition of cell-cell fusion by
each of these peptides, it is thought that HR1 and HR2 do-
mains do not form the coil-coil, 6HB prior to fusion activation
and are complexed only in the postfusion form (22, 41, 55).
Subsequent studies of structures of F protein from different
paramyxoviruses showed that F protein may exist in two dif-
ferent forms. One form, exemplified by the structures of para-
influenza virus 3 F protein (53) and NDV F protein (6), is
proposed to be in postfusion conformation because the struc-
tures contain the two HR domains complexed in the 6HB
form. Another structure was derived from a soluble form of
PIV5 F protein (54), which was stably trimerized by fusing the
carboxyl terminus of the HR2 domain to the yeast GCN4
sequence, preventing 6HB formation between HR2 and HR1
domains. This structure was proposed to be the prefusion form
of F protein. Changes in F protein conformation were also
explored by defining the effects of HR1 and HR2 peptides (41)
and mutations in HR1 and HR2 domains (16, 24, 30, 36, 42, 44,
51) on cell-cell fusion at different temperatures. Based on
these studies, it was proposed that paramyxovirus F protein
undergoes a series of major conformational changes leading to
final 6HB formation (41).
The trigger for this major refolding of F protein is thought to
be binding of the HN protein to its receptor. Whether other
factors, besides interaction of F protein with HN protein, play
a role in activation of F protein has not been explored. Nor is
it clear how the F protein accomplishes the major refolding
proposed to occur concomitant with membrane fusion. One
potential mechanism to facilitate this refolding is disulfide
bond isomerization or disruption, as suggested by studies of
retrovirus envelope proteins. It has been shown that one or
multiple disulfide bonds in human immunodeficiency virus
(HIV) Env are reduced, at the time of membrane fusion,
facilitating refolding of Env (5, 10, 12, 25, 43). The appearance
of free cysteine residues in the HIV Env protein is mediated by
host protein disulfide isomerase (PDI) or related thiol isomer-
ases that are present on cell surfaces (11, 25). In some other
retroviruses, such as murine leukemia virus, the thiol/disulfide
isomerization is thought to be mediated by an isomerase motif,
Cys-X-X-Cys (CXXC), in the viral Env glycoprotein, the ac-
tivity of which is triggered by receptor binding (37, 49, 50).
Recently, entry of other viruses, for example, Sindbis virus (1)
and avian leukosis virus A (45), has been shown to be depen-
dent on appearance of free thiols in viral fusion proteins. It has
also been shown that the conserved cysteine residues of the
hepatitis B virus envelope protein in hepatitis delta virus are
* Corresponding author. Mailing address: Department of Molecular
Genetics and Microbiology, University of Massachusetts Medical
School, 55 Lake Avenue North, Worcester, MA 01655. Phone: (508)
856-6592. Fax: (508) 856-5920. E-mail: trudy.morrison@umassmed
.edu.
 Published ahead of print on 15 October 2008.
241
 at UNIV O
F M
ASS M
ED SCH on Novem
ber 30, 2009 
jvi.asm.org
D
ow
nloaded from
 
required for virus entry and that entry is inhibited by mem-
brane-impermeable inhibitors of thiol/disulfide isomerases (2).
Thiol/disulfide isomerases, including PDI, are a family of 19
structurally related proteins with a thioredoxin-like domain (as
reviewed in reference 3). Most of these isomerases have a
CXXC motif that catalyzes formation, reduction, and rear-
rangement of the disulfide bonds in proteins (3, 9, 34, 52).
These isomerases are primarily involved in the folding of pro-
teins in the endoplasmic reticulum, catalyzing formation of
disulfide bonds, and most of these proteins have endoplasmic
reticulum retention signals (3). However, in recent years,
isomerases from the PDI family have also been shown to be
present on cell surfaces, both in functional and in biochemical
assays (reviewed in reference 11). The mechanisms involved in
the expression and retention of these proteins at cell surfaces
are unknown, but it has been speculated that they may be
bound to resident host cell surface proteins (3, 11, 14, 48). Cell
surface disulfide isomerases are proposed to be involved in
processes such as cell adhesion, nitric oxide signaling, and
reduction of disulfide bonds in cell entry proteins of viruses
(reviewed in references 11, 19, and 48).
We have reported previously that free thiols are detected in
cell surface-expressed NDV F protein and that the presence of
free thiols is required for virus entry into cells, as well as for
cell-cell fusion in cells expressing NDV glycoproteins (18). We
also reported that the fusion of membranes in cells expressing
NDV glycoproteins is inhibited by free thiol blockers at a very
early step, before hemifusion (18). How the appearance of free
thiols correlates with F protein activation or with conforma-
tional changes during membrane fusion is unknown.
In this report we show that free thiols are not present in F
protein on the surface of virions or virus-like particles (VLPs)
but are produced after binding of virus or VLPs to the target
cells. We also correlated the appearance of free thiols in F
protein in virus and VLPs to the conformational changes pro-
posed to occur in F protein and to the activation of F protein
by HN protein. Our results suggest that free thiols are pro-
duced in F protein on surfaces of virus or VLPs only after
attachment to cells but before any major proposed conforma-
tional changes in F protein and that the appearance of free
thiols is independent of activation of F protein by HN protein.
MATERIALS AND METHODS
Cells, virus, and antibodies. COS-7 cells, obtained from American Type Cul-
ture Collection, were grown in Dulbecco modified Eagle medium (DMEM)
(Gibco) supplemented with nonessential amino acids, vitamins, penicillin, and
streptomycin, and 10% fetal calf serum (FCS). East Lansing Line (ELL-0) avian
fibroblasts, obtained from American Type Culture Collection, were maintained
in DMEM supplemented with penicillin-streptomycin and 10% FCS. Guinea pig
red blood cells (RBCs) were obtained from Bio-Link, Inc.
NDV, strain Australia-Victoria (AV), was propagated in embryonated chicken
eggs by standard protocols (26) in BCL-3 containment.
Anti-HR2 antibody was raised against peptide with sequence from the NDV F
protein HR2 domain (29). Anti-NDV antibody was raised in rabbits against
UV-inactivated stocks of NDV (strain AV), by standard protocols as previously
described (28). Mouse monoclonal Anti-PDI antibody was purchased from Ab-
nova Corp. Anti-AS, an antibody specific for the HN protein, was raised against
a sequence in the NDV HN protein as previously described (29).
Plasmids. NDV HN, F, M, and NP cDNAs, subcloned in pCAGGS vector as
described previously (29, 35), were used for transfection. F protein gene with
mutations in the HR1 domain (N147K) and the HR2 domain (L488,495K)
regions have been described previously (40, 44). HN protein gene mutants (HN
I133L and HN V81A/L110A) have been described previously (13, 47).
Transfections. Transfection of cells was accomplished by using Lipofectamine
(Invitrogen) as recommended by the manufacturer. For each transfection, a
mixture of DNA (0.5 g/35 mm plate) and 7 l of Lipofectamine in OptiMEM
(Gibco/Invitrogen) was incubated at room temperature and added to cells pre-
viously washed with OptiMEM. The cells were incubated for 5 h, and OptiMEM
was replaced with 2 ml of supplemented DMEM.
Production and purification of VLPs. VLPs were generated from avian cells
and purified as described previously (35). Briefly, cells were transfected with
cDNAs (4 g of each/100-mm plate) encoding NDV HN, F, M, and NP proteins.
Supernatant from the cells was collected at 24, 48, and 72 h and was clarified by
centrifugation at 5,000 rpm for 5 min at 4°C. The clarified supernatant was
overlaid on top of a step gradient consisting of 1 ml of 20% and 0.5 ml of 65%
sucrose solutions in TNE buffer (25 mM Tris-HCl [pH 7.4], 150 mM NaCl, 5 mM
EDTA), and centrifuged at 24,000 rpm for 12 h at 4°C using an SW50.1 rotor
(Beckman). The interface (containing concentrated particles) was collected in a
1-ml volume using a polystaltic pump, mixed with 1 ml of 80% sucrose, and
overlaid on top of a 1-ml 80% sucrose cushion. Additional layers of sucrose (1 ml
of 50% and 0.5 ml of 10% sucrose) were layered on top of the particle containing
interface. The gradient was centrifuged at 38,000 rpm for 16 h at 4°C. The top 2
ml of the gradient containing particles was collected by using a polystaltic pump,
mixed with 3 ml of TNE buffer, and pelleted by centrifuging at 38,000 rpm for 6 h
at 4°C. The pellet was dissolved in 100 l of TNE and used as VLP stock.
MPB labeling of virions and VLPs. Equal quantities of NDV (AV strain)
virions or VLPs were divided into aliquots into three separate tubes. Set 1 was
treated with 5 mM dithiothreitol (DTT; Sigma-Aldrich, Inc.) for 1 h at 37°C,
while the other two sets received no treatment. To remove DTT, virions or VLPs
were purified by centrifugation on a step gradient consisting of 1-ml 20% and
0.5-ml 65% sucrose solutions in TNE buffer at 24,000 rpm for 8 h at 4°C. The
interface containing purified particles was collected and set 1 and 2 particles were
incubated with MPB [3-(N-maleimidylpropionyl)biocytin; Molecular Probes] at
room temperature for 30 min. Set 3 particles were negative controls. To remove
unbound MPD, virions or VLPs were purified by centrifugation through layer of
20% sucrose solution in TNE buffer at 24,000 rpm for 8 h at 4°C. The pellet was
dissolved in 100 l of RSB lysis buffer (0.01 M Tris-HCl [pH 7.4], 0.01 M NaCl,
1.5 mM MgCl2) containing 1% Triton X-100, 0.5% sodium deoxycholate, 2.5 mg
of N-ethylmaleimide per ml, and 0.2 mg of DNase per ml, and the proteins were
precipitated with neutravidin-agarose that had been washed sequentially with
phosphate-buffered saline (PBS) containing 0.5% Tween 20 and 5 mg of bovine
serum albumin/ml and with PBS containing 0.5% Tween 20 and 1 mg of BSA/ml
and that contained 0.3% sodium dodecyl sulfate (SDS). Precipitates were washed
three times with PBS containing 0.5% Tween 20 and 0.4% SDS and resolved by
SDS-polyacrylamide gel electrophoresis (PAGE).
Labeling of virions and VLPs with MPB in the presence of RBCs. Guinea pig
RBCs were washed in PBS containing 0.1 mM CaCl2 and 1 mM MgCl2 (PBS-
CM) and resuspended in PBS-CM to give a 0.4% solution by volume. RBCs were
counted, and nearly 106 cells were incubated with NDV (AV strain) (multiplicity
of infection of 100) or VLPs in the presence or absence of MPB (0.5 mM) for
1 h. Unbound virions or VLPs along with free MPB were removed by washing
RBCs three times with PBS-CM. Washed RBC pellet was lysed with RSB lysis
buffer and analyzed for labeling by MPB as described above.
PAGE and Western blot analysis. Proteins in extracts of cells, virions, or VLPs
lysed with RSB buffer or immunoprecipitates, diluted in gel sample buffer (125
mM Tris-HCl [pH 6.8], 2% SDS, 10% glycerol) with 0.7 M -mercaptoethanol,
were resolved on 10% polyacrylamide gels. After electrophoresis, gels were
equilibrated in transfer buffer (25 mM Tris [pH 8.2], 192 mM glycine, 15%
methanol) and transferred to Immobilon-P (Millipore Corp.) membranes. The
membranes were blocked overnight at 4°C in PBS containing 0.5% Tween 20 and
10% nonfat milk, washed with PBS-Tween 20, and incubated for 1 h at room
temperature with primary antibody diluted to 1:1,000 in PBS-Tween 20. Mem-
branes were then washed, incubated for 1 h at room temperature with secondary
antibody (goat anti-rabbit immunoglobulin G [IgG] or anti-mouse IgG coupled
to horseradish peroxidase) (Amersham Biosciences) diluted to 1:40,000 in PBS-
Tween 20 and then washed extensively in PBS-Tween 20. Bound antibody was
detected by using the ECL Western blotting detection reagent system (Amer-
sham Biosciences). Quantification of the signal was accomplished by using a
Fluor-S imager (Bio-Rad).
Plaque assay. NDV virus (AV strain) was incubated with MPB and purified by
centrifugation through sucrose gradients as described above. Purified virus was
serially diluted in Ca2-rich medium and then added to confluent avian cells. As
a control, unlabeled virus was similarly purified, serially diluted, and added to the
cells with or without MPB (0.5 mM). After adsorption for 45 min at 37°C,
unbound virus was removed and agar diluted to 1% in DMEM and supple-
mented with nonessential amino acids, vitamins, penicillin-streptomycin, sodium
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bicarbonate, and 10% FCS was then placed over the monolayers. After 48 h of
incubation, the plaques were counted.
RESULTS
Detection of free thiols in F protein in virions upon cell
binding. To determine whether free thiols are present in F
protein in virions, we utilized MPB, which is a membrane-
impermeable, thiol-reactive, biotin-containing compound that
links to free thiols and biotinylates proteins with free thiols
(18). We have previously reported that NDV F protein, ex-
pressed on the surfaces of cells transfected with cDNA encod-
ing the F protein, is labeled with this reagent, indicating the
presence of free thiols in the molecule (18). Virions were
incubated with MPB and then repurified to remove unbound
MPB and lysed. Proteins in lysed virions were analyzed for
MPB labeling by precipitating with neutravidin-agarose. As
shown in Fig. 1A (lane 6), F protein in virions was not labeled
by MPB, whereas in virions treated with DTT, a reducing agent
(lane 7), prior to incubation with MPB, F protein was labeled
with MPB. This result indicated that F protein in virions does
not have free thiols.
We have previously shown that detection of free thiols in
surface-expressed F protein was suppressed by membrane im-
permeable inhibitors of isomerases belonging to PDI family
(18). One possibility for the absence of free thiols in F protein
in virions is that PDI-like isomerases are not packaged into the
virions. To determine whether PDI is present in virions, we
analyzed virion-associated proteins by Western analysis using
anti-PDI antibody. As shown in Fig. 1B (lanes 4 to 6), PDI was
not detected in virion extracts, while PDI was detected in
extracts from infected (lanes 7 to 9) or uninfected (lanes 1 to
3) COS-7 cells. Similarly, we also detected PDI in extracts from
avian cells and guinea RBCs (Fig. 1C).
We have previously reported that isomerase inhibitors block
virus infection (18). Thus, failure to detect free thiols in virion-
associated F protein suggested that free thiols may be pro-
duced in virion-associated F protein only after binding to tar-
get cells. To test this possibility, we incubated virions with
guinea pig RBCs in the presence of MPB. RBCs were washed
to remove unbound virus, as well as soluble MPB. F protein in
bound virions present in the RBCs extract was then analyzed
for MPB labeling. As shown in Fig. 1D (lane 4), virion F
protein was labeled by MPB in the presence of RBCs. This
result suggested that free thiols are produced in F protein only
after binding to target cells.
Effect of MPB labeling of virions on infectivity. We have
previously shown that MPB linkage to F protein inhibits cell-
cell fusion (18). If free thiols in virion F protein are produced
only after the addition of target cells, then incubation of virions
with MPB prior to adding target cells should not have any
effect on their infectivity, while incubation of virus with MPB
during virus attachment to cells should inhibit infection. To
test this proposal, we incubated virions with MPB and then
repurified virions to remove unbound MPB. Infectivity of re-
purified virions was compared to infectivity of virions not pre-
viously treated with MPB and to infectivity of virus added to
target cells in the presence of MPB. A plaque assay was con-
ducted in the presence of MPB, yielding the following results
in PFU/ml for the indicated virus treatment groups: no treat-
ment, 1.45  0.2  109; MPB before infection, 1.17  0.14 
109; and MPB during infection, 1.07  0.83  108. Virions in
the “MPB before infection” group were treated with MPB and
FIG. 1. Detection of free thiols in virions after cell binding. (A) Virions were incubated with MPB (lanes 3 and 6), analyzed for MPB labeling
of F protein by precipitating with neutravidin-agarose (lanes 5 to 7), and detected by Western blotting with anti-HR2 antibody. Untreated virions
(No Tt, lanes 2 and 5) and virions treated with DTT prior to incubation with MPB (lanes 4 and 7) were used as controls. Total F protein in extracts
from virions (lanes 2 to 4) was resolved as a control for the amounts of virions. (B) Increasing amounts of extracts from virions (lanes 4 to 6) and
COS-7 cells either uninfected (lanes 1 to 3) or infected with NDV (lanes 7 to 9) were resolved by SDS-PAGE and detected for PDI (top panel)
and NP protein (bottom panel). (C) Increasing amounts of extracts from avian cells and guinea pig RBCs were resolved by SDS-PAGE and
detected for PDI. (D) Virions were incubated with RBCs and MPB at 4°C for 1 h, followed by 22°C for 15 min, shown in lanes 4 and 7. RBCs
incubated with MPB alone (lanes 2 and 5) or virus alone (lanes 3 and 6) were used as controls. Unbound virions and MPB were removed, and
F protein in bound virions was analyzed for MPB labeling by precipitation with neutravidin-agarose (lanes 2 to 4), followed by detection with
anti-HR2 antibody. Extracts from RBCs (lanes 5 to 7) were resolved as a control for the amount of virus bound to RBCs.
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purified before being added to the cells. For the “MPB during
infection” group, MPB was added to the cells at the time of
infection, and unbound virions as well as MPB were removed
before the agar overlay was added. These results show that
infectivity of virions pretreated with MPB was not significantly
different from that of unlabeled virions consistent with absence
of MPB labeling. In contrast, the infectivity of virions added to
target cells in the presence of MPB was 10-fold lower than
that of unlabeled virions, a result consistent with the genera-
tion of free thiols upon virus binding.
Detection of free thiols in F protein in VLPs after cell bind-
ing. We have previously reported that avian cells expressing
the NDV NP (nucleocapsid protein), M (membrane), HN, and
F proteins release VLPs that resemble virus both biochemi-
cally and morphologically (35). Because we wanted to explore
MPB labeling of different F protein mutants and F protein in
the presence of HN protein mutants in particles, we deter-
mined whether free thiols are present in F protein in VLPs.
NDV VLPs were incubated with MPB, and VLPs were then
repurified to remove unbound MPB. Proteins in VLP extracts
were analyzed for MPB binding by precipitating with neutra-
vidin-agarose. The results in Fig. 2A (lane 3) show that, similar
to F protein in virions, F protein in VLPs was not labeled by
MPB, whereas F protein in VLPs treated with DTT (lane 4)
prior to incubation was labeled with MPB.
To determine whether free thiols are produced in F protein
in VLPs after the addition of target cells, VLPs were incubated
with RBCs in the presence of MPB. RBCs were washed to
remove unbound VLPs, as well as soluble MPB. F protein in
bound VLPs present in RBC extracts was then analyzed for
MPB labeling. As shown in Fig. 2B (lane 3), F protein in VLPs
was labeled by MPB in the presence of RBCs. These results
suggested that free thiols, similar to virions, are produced in F
protein in VLPs only after binding to target cells.
Production of free thiols in F protein in different tempera-
ture-arrested conformations. It has been previously docu-
mented that conformational changes in paramyxovirus F pro-
tein upon activation can be arrested at low temperatures (41).
The first intermediate, susceptible to HR1 peptide binding,
was proposed to exist at 15°C, while another intermediate
form, susceptible to both HR1 and HR2 peptides, was shown
to exist only at 37°C.
To determine the earliest form of F protein with detectable
free thiols, we characterized MPB labeling of temperature
arrested intermediates of F protein in VLPs and in virions. For
these studies, we first determined the efficiency of MPB label-
FIG. 3. MPB labeling of temperature arrested intermediates of F
protein in VLPs. (A) VLPs were treated with DTT and labeled with
MPB at 4°C (lanes 2 and 6), 16°C (lanes 3 and 7), 22°C (lanes 4 and 8),
or 37°C (lanes 5 and 9). F protein in VLPs was analyzed for labeling
with MPB by precipitation with neutravidin-agarose (lanes 2 to 5), and
extracts from VLPs (lanes 6 to 9) were resolved as a control for
amount of VLPs. (B) VLPs were incubated with RBCs with (lanes 7 to
10 and lanes 16 to 19) or without MPB (lanes 3 to 6 and lanes 12 to 15)
at the indicated temperatures. RBCs incubated with MPB in the ab-
sence of VLPs (lanes 2 and 11) were used as a control. Unbound VLPs
and MPB were removed, and F protein in bound VLPs was analyzed
for MPB labeling by precipitation with neutravidin-agarose (lanes 2 to
10), followed by Western analysis with anti-HR2 antibody. Extracts
from RBCs (lanes 11 to 19) were resolved as control for the amount of
VLPs bound to RBCs. (C) Quantification of MPB labeling of temper-
ature arrested intermediates of F protein in VLPs. F protein bands in
Western blots (B) were quantified by using a densitometer, and the
values for MPB labeling (lanes 2 to 10) were normalized for binding
(lanes 11 to 19) at respective temperatures and expressed as a per-
centage of labeling at 22°C. Error bars indicate the range obtained in
three independent experiments. Quantification was accomplished us-
ing blots exposed in linear range of film.
FIG. 2. Free thiols appear in VLPs after cell binding. (A) VLPs were
incubated with MPB (lanes 3 and 6) and analyzed for MPB labeling of F
protein by precipitation with neutravidin-agarose (lanes 2 to 4), followed
by Western analysis with anti-HR2 antibody. Untreated VLPs (No Tt,
lanes 2 and 5) and VLPs treated with DTT prior to incubation with MPB
(lanes 4 and 7) were used as controls. Total F protein in extracts from
VLPs (lanes 5 to 7) was resolved as a control for the amounts of VLPs.
(B) VLPs were incubated with RBCs and MPB at 4°C for 1 h, followed by
22°C for 15 min (lanes 3 and 6). RBCs incubated with MPB alone (lanes
1 and 4) or VLPs without MPB (lanes 2 and 5) were used as controls.
Unbound VLPs and MPB were removed, and F protein in bound VLPs
was analyzed for MPB labeling by precipitation with neutravidin-agarose
(lanes 1 to 3). Extracts from RBCs (lanes 4 to 6) were resolved as a control
for the amount of VLPs bound to RBCs.
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ing at different temperatures by incubating DTT-treated VLPs
with MPB at 4, 16, 22, and 37°C. As shown in Fig. 3A (lanes 2
to 5), labeling of F protein in VLPs by MPB was comparable at
all of the temperatures.
Next, we assessed MPB labeling of F proteins in VLPs when
incubated with RBCs at 4, 16, 22, and 37°C. RBCs were washed
to remove unbound VLPs, as well as MPB. F protein in bound
VLPs present in RBC extracts was then analyzed for MPB
labeling. A representative result is shown in Fig. 3B, and the
quantification of three similar experiments is shown in Fig. 3C.
As shown in Fig. 3B (lanes 7 to 10), F protein in VLPs was
labeled by MPB at all of the incubation temperatures. Labeling
of F protein in VLPs incubated at 4°C was significantly de-
creased, while labeling at other temperatures was comparable
when normalized to VLP binding to RBCs (Fig. 3C).
Similar results were seen after binding of virions to RBCs at
different temperatures. As shown in Fig. 4A (lanes 4 to 7), F
protein in virions was labeled by MPB at all of the incubation
temperatures. Labeling of F protein in RBC-bound virions
incubated at 4°C was significantly decreased, while labeling at
other temperatures was comparable when normalized to virus
binding (Fig. 4B). These results suggest that free thiols are
produced in F protein before the major proposed conforma-
tional changes in F protein.
Production of free thiols in HR1 and HR2 mutant F pro-
teins. HR2 and HR1 mutant F proteins are thought to be
defective in attaining the prehairpin (diagramed in Fig. 7C)
intermediate conformation (27, 36, 42, 44, 51). To determine
whether these mutant proteins can form free thiols, we gener-
ated VLPs containing wild-type F protein or HR1 (N147K) or
HR2 (L488,495K) mutant F proteins. Proteins in VLPs con-
taining wild-type F protein or F protein with mutations in HR1
(N147K) or HR2 (L488,495K) domain are shown in Fig. 5A.
The amounts of VLPs were equalized by normalizing to the
NP/F1 protein band. Equivalent amounts of VLPs were labeled
by MPB in the presence of RBCs and analyzed. That the
FIG. 4. MPB labeling of temperature-arrested intermediates of F
protein in virions. (A) Virions were incubated with RBCs and MPB (lanes
4 to 7 and lanes 10 to 13) at the indicated temperatures. RBCs incubated
with MPB in the absence of virions (lanes 2 and 8) and virions without
MPB at 22°C (lanes 3 and 9) were used as controls. Unbound virions
and MPB were removed, and F protein in bound virions was analyzed for
MPB labeling by precipitation with neutravidin-agarose (lanes 2 to 7).
Extracts from RBCs (lanes 8 to 13) were resolved as a control for the
amount of virions bound to RBCs. (B) Quantification of MPB labeling of
temperature-arrested intermediates of F protein in virions. F protein
bands in Western blot (A) were quantified by using a densitometer, and
the values for MPB labeling (lanes 2 to 7) were normalized for binding
(lanes 8 to 13) at respective temperatures and expressed as a percentage
of labeling at 22°C. Error bars indicate the range obtained in three inde-
pendent experiments. Quantification was accomplished by using blots
exposed in a linear range of film.
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FIG. 5. MPB labeling of F mutants in VLPs. (A) VLPs were gen-
erated using Fwt (lane 1) or HR1 mutant, F (N147K) (lane 2) or HR2
mutant, F (L488,495K) (lanes 3 and 4). The amounts of VLPs gener-
ated in each case were estimated by detecting particle associated pro-
teins by a Western blot using a mix of anti-NDV antibody, anti-F
antibody, and anti-HN (anti-AS) antibody. The protein band below the
NP protein (*) is a degradation product of NP variably seen in differ-
ent preparations of virus and VLPs (unpublished observation). The
protein band below the HN protein (*) is a nonspecific protein band
variably detected by anti-AS antibody, an anti-HN antibody.
(B) Equivalent amounts of VLPs (normalized to NP protein shown in
panel A) with Fwt (lanes 2 and 6) or HR1 mutant F (N147K) (lanes 3
and 7) or HR2 mutant F (L488,495K) (lanes 4 and 8) were incubated
with RBCs and MPB at 4°C for 1 h, followed by 22°C for 15 min. RBCs
incubated with MPB in the absence of VLPs (lanes 1 and 5) were used as
a control. Unbound VLPs and MPB were removed, and F protein in
bound VLPs was analyzed for MPB labeling by precipitation with neu-
travidin-agarose (lanes 1 to 4), followed by Western analysis with anti-
HR2 antibody. Extracts from RBCs (lanes 5 to 8) were resolved as a
control for the amount of VLPs bound to RBCs. (C) Quantification of
MPB labeling in panel B. The results are representative of two similar
experiments. Quantification was accomplished using blots exposed in a
linear range of film. As shown in Fig. 1 to 4 and in other experiments,
there was no nonspecific precipitation of wild-type or mutant F protein
with neutravidin-agarose in the absence of MPB binding.
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amounts of VLPs used were comparable is confirmed by com-
parable amounts of F protein in bound VLPs containing wild-
type F protein (Fig. 5B, lane 6) or HR1 or HR2 mutant F
proteins (lanes 7 or 8). As shown in Fig. 5B, HR1 mutant F
protein (lane 3) was labeled by MPB as well as wild-type F protein
(lane 2). The HR2 mutant F protein (lane 4) was also labeled with
MPB. Interestingly, this mutant F protein was labeled with MPB
at significantly higher levels compared to the wild-type F protein.
That both mutant proteins had free cysteine residues suggested
that free thiols are produced before any major conformational
change in F protein. These results also suggest that F protein with
an HR2 mutation may be more accessible to isomerases than
wild-type or HR1 mutant proteins.
Role of HN protein in production of free thiols in F protein.
We have previously reported that, in transfected cells, free
thiols were detected in F protein when it was expressed alone,
without HN protein (18). This result suggested that production
of free thiols in F protein is independent of HN protein in
transfected cells. To determine the role of HN protein in
production of free thiols in F protein in VLPs, we analyzed
VLPs containing mutant HN protein (HN I133L and HN
V81A/L110A) for labeling of F protein by MPB. These mutant
HN proteins have alterations in the stalk domain and have
been shown to be defective in fusion promotion but are com-
parable to wild-type HN protein in attachment activity (13, 46).
Figure 6A shows the proteins incorporated in VLPs containing
wild-type or mutant HN proteins. The amounts of VLPs were
equalized by normalizing to the NP/F1 protein band. Equiva-
lent amounts of VLPs were labeled by MPB in the presence of
RBCs and analyzed. Figure 6B, lanes 6 and 7, show that the
amounts of VLPs used were comparable since the amounts of
F protein in bound VLPs were similar in VLPs containing
wild-type or mutant HN protein. The F protein in VLPs con-
taining mutant HN protein migrates slightly faster on the gel
than F protein in VLPs with wild-type HN protein (Fig. 6B,
lanes 6 and 7). This difference may be due to the treatment of
cells with neuraminidase during production of VLPs contain-
ing mutant HN proteins since these mutants are defective in
neuraminidase activity (13, 46). Lower neuraminidase activity
inhibits release of VLPs from cells (unpublished observation).
As shown in Fig. 6B (lane 4), F protein in VLPs containing
these mutant HN proteins was labeled by MPB at levels similar
to VLPs containing wild-type HN protein. This result sug-
gested that the production of free thiols in F protein in VLPs
is independent of HN protein activation.
DISCUSSION
Paramyxovirus F proteins are thought to undergo major
conformational changes during membrane fusion. These
changes are required for the fusion process and are triggered
by HN protein binding to the host cell receptors. How F pro-
tein accomplishes this refolding is not clear. One possible
mechanism proposed to facilitate refolding of the F protein is
reduction of disulfide bonds in F protein by host cell thiol/
disulfide isomerases (18). We have previously reported that
free thiols are present in cell surface-expressed F protein and
that these free thiols are required for fusion mediated by F
protein (18). In the present study we found that free thiols
cannot be detected in purified virions or VLPs. However, free
thiols could be detected upon binding of the particles to cell
surfaces. We further defined the relationship of the appear-
ance of these reduced forms of particle-associated F protein to
F protein activation by HN protein and the conformational
changes in F protein upon activation.
FIG. 6. (A) MPB labeling of F protein in VLPs with HN mutants.
(A) VLPs were generated using HNwt (lane 1) or HN (I133L) (lanes
2 and 3) or HN (V81A/L110A) (lane 5) separately. The amounts of
VLPs generated in each case were estimated by detecting proteins
associated to VLPs by SDS-PAGE and analyzing them by Western
blotting using a mix of anti-NDV antibody, anti-F antibody, and an-
ti-HN antibody. The protein band below NP protein (*) is a degrada-
tion product of NP variably seen in different preparations of virus and
VLPs (unpublished observation). The protein band below HN protein
(*) is a nonspecific protein band variably detected by anti-AS antibody.
(B) Equivalent amounts of VLPs (normalized to NP protein shown in
A) with HNwt (lanes 3 and 6) or HN mutant HN I133L (top panel) or
HN V81A/L110A (bottom panel) (lanes 4 and 7) were incubated with
RBCs and MPB at 4°C for 1 h, followed by 22°C for 15 min. RBCs
incubated with MPB in the absence of VLPs (lanes 1 and 5) were used
as a control. Unbound VLPs and MPB were removed, and F protein in
bound VLPs was analyzed for MPB labeling by precipitation with
neutravidin-agarose (lanes 2 to 4), followed by Western analysis with
anti-HR2 antibody. Extracts from RBCs (lanes 5 to 7) were resolved as
a control for the amount of VLPs bound to RBCs. (C) Quantification
of MPB labeling in panel B. The results are representative of two
similar experiments. Quantification was accomplished using blots ex-
posed in a linear range of film. As shown in Fig. 1 to 4 and in other
experiments, there was no nonspecific precipitation of F protein with
neutravidin-agarose in the absence of MPB binding.
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The position and numbers of cysteine residues in paramyxo-
virus F proteins are highly conserved (31). In Sendai virus F
protein, it has been shown that all of the cysteines in virion
associated F protein are involved in disulfide bonds (17). Al-
though the linkages between the extracellular cysteine residues
in the NDV F protein have not been directly demonstrated, it
is likely that the disulfide bonding is similar to that of Sendai
virus F protein. Indeed, our results showing lack of MPB la-
beling of F protein in purified virions suggest that there are no
free thiols in virion-associated F protein and all cysteines are
involved in disulfide bonds (Fig. 1). Consistent with this obser-
vation is the absence of PDI isomerase in virus membranes. It
has been reported that cell surface PDI is not associated with
lipid raft domains (25). We have previously reported that NDV
is assembled in lipid raft domains (20); thus, the failure to
package PDI into virions is not surprising.
Free thiols were, however, detected in virions and VLPs
bound to RBCs and incubation with MPB could inhibit plaque
formation only if it was present during particle binding to cell
surfaces (Fig. 1 and 2 and Table 1). These results suggested
that particles must bind to cell membranes to be exposed to the
cell surface host cell isomerases and only then are F protein
disulfide bonds reduced. Although thiol isomerases have not
been reported on RBC surfaces, surface expression of these
enzymes has been documented in numerous cell types (re-
viewed in reference 11), including COS-7 cell surfaces (18a).
According to current models proposed for paramyxovirus
membrane fusion, F protein undergoes major refolding upon
activation (41, 54). The first proposed conformational change
in F protein is the disassociation of HR2 domains in the trimer.
Subsequently, the HR1 domain unfolds and then refolds into
an extended trimeric helix resulting in the insertion of the
fusion peptide, which is at the tip of the helix, into target cell
membranes. F protein in this state is referred to as prehairpin
intermediate. After insertion of fusion peptide into the target
membrane, the next proposed major conformational change
involves refolding of F protein into a stable trimer of hairpins
formed by complexing of the HR1 and HR2 domains into a
6HB. The refolding of F protein into this postfusion form leads
to the close approach and fusion of the target and effector
membranes.
Conformational intermediates in F protein refolding have
been defined previously by evaluating inhibition of cell-cell
fusion after HR1 or HR2 peptide binding at temperatures
lower than 37°C, reasoning that, at lower temperatures, the
energy available for F protein refolding is suboptimal (41).
Based on their results, Russell et al. (41) have proposed that F
protein at 4 or 15°C is arrested in a prefusion or open stalk
state as shown in Fig. 7. Our results (Fig. 3 and 4) that F
protein in virions or VLPs is labeled by MPB at 16°C, at levels
comparable to those at 22 or 37°C, suggest that free thiols are
produced in F protein before any major conformational
changes in F protein take place. The decrease in MPB labeling
seen at 4°C compared to 16°C could be due to lower activity of
host cell isomerases at this temperature.
We also observed a decrease in binding of virions to RBCs
at 37°C in the presence of MPB (Fig. 4). One possibility for this
decrease in binding is that neuraminidase activity of HN pro-
tein at this temperature leads to disassociation of bound viri-
ons. Since MPB inhibits fusion (18), the F protein with bound
MPB may not insert its fusion peptide into the target mem-
branes. In this case, the F protein may not anchor the virus to
target cells facilitating release of the particles from the cells by
the HN protein neuraminidase (38). A failure of F protein to
anchor to target cells in the presence of MPB is consistent with
the proposal that free thiols are produced before the prehair-
pin intermediate of F protein is formed. It is this form of F
protein, with the FP domain extended toward the target mem-
brane, which is thought to insert into target membranes.
Studies of HR1 and HR2 F protein mutants from different
paramyxoviruses have shown that mutations in these domains
affect its fusion activity (16, 24, 30, 36, 42, 44, 51). Mutations in
HR2 domain were proposed to be arrested in an early inter-
mediate form, before prehairpin formation (42), and muta-
tions in HR1 domain were proposed to be defective in attain-
ing a stable prehairpin conformation (24, 42, 51). Our results
(Fig. 5) showed that both HR1 and HR2 mutant F proteins
have free thiols and suggest that free thiols are produced in
either a prefusion form or a form with open HR2 stalk domain
of F protein. That is, the appearance of free thiols occurs in a
conformation that forms prior to the point at which the mutant
proteins are arrested. The increase in labeling of HR2 mutant
F protein suggests that a larger percentage of the total HR2
mutant F protein contains free thiols. The increased amount of
HR2 mutant protein in a reduced form could be due to the
packaging of a reduced form of this protein into VLPs. How-
ever, this explanation is less likely since there are not increased
levels of reduced forms of this protein on surfaces of cells
transfected with this mutant protein (unpublished observa-
tions). Rather, it is possible that the HR2 mutant F protein in
bound VLPs may be more accessible to isomerases or that this
mutant protein is arrested in an early reduced form while the
HR1 mutant proteins may be arrested in a later stage and
would include both reduced and disulfide linked forms as does
the wild-type protein.
FIG. 7. Model for the role of free thiols in virion-associated F
protein. (A) F protein in prefusion conformation. HN protein binds to
the receptor and facilitates interaction between F protein and target
cell isomerases. This binding leads to cleavage of disulfide bond in F
protein (B) in prefusion or open stalk conformation, which has been
shown to be present at lower temperatures. (C) F protein in prehairpin
conformation, which has been shown to require 37°C. (D) F protein in
postfusion conformation. HR1 and HR2 mutants are proposed to be
defective in attaining form C and are arrested in form B, an open stalk
conformation.
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For paramyxovirus F protein activity, binding of HN protein
to its receptor has been shown to be essential (33, 39). This
requirement for HN protein for fusion is virus specific, sug-
gesting that there is an essential interaction between HN and
F proteins (15). The details of this interaction are not clear,
and whether other factors are involved in F protein activation
is not yet known. We have shown previously that while the
production of free thiols in F protein is required for cell-cell
and virus-cell fusion, free thiols can be detected in F protein
expressed on cell surfaces without HN protein (18). These
results suggest that reduction of disulfides and interactions
with HN protein are independently required for fusion activa-
tion. This conclusion is supported by our finding that MPB
linkage to F protein was unaffected by the presence of HN
proteins which were attachment competent but defective in
fusion activation (Fig. 6). This finding suggests that during
virus entry, HN protein binding to its receptor facilitates pro-
duction of free thiols in F protein by bringing the F protein to
proximity of cell surface isomerases and that interaction be-
tween HN and F proteins leading to activation of F protein is
not required for the production of free thiols in F protein.
Upon making contact with cell surfaces or in transfected cell
membranes, the prefusion F protein may be in equilibrium
between oxidized and reduced forms. If HN protein is present,
the F protein with free thiols may proceed to refold, resulting
in membrane fusion. Refolding is blocked if the free cysteines
are blocked with MPB (Fig. 7), and fusion is inhibited as shown
here and in previous results (18).
Comparisons of the positions of the cysteine residues in the
proposed pre- and postfusion structures of paramyxovirus F
proteins suggest that the disulfide bond linkages in the two
forms are identical. That is, there is no evidence for a reshuf-
fling of disulfide bonds upon the change from the prefusion to
postfusion forms of the protein. Thus, it may only be the
transient disruption of the bonds that facilitates the refolding
of the F protein. Disruption of some bonds may decrease the
activation energy required or may facilitate the refolding of the
molecule. Another possible mechanism may be a necessary
transient covalent disulfide bond between the fusion protein
and a host cell protein. Actual reshuffling of disulfide bonds
has been demonstrated in the murine leukemia virus Env pro-
tein. It is not clear whether reshuffling of disulfide bonds oc-
curs in the avian leukosis virus Env, the HIV Env, the alpha-
virus envelope protein, or the hepatitis delta virus envelope
protein.
It has been recently reported that F protein in Sendai virus
virions is a mixed population of prefusion and postfusion forms
(23). If the NDV F protein in particles exists in both forms,
then our results indicate that neither the pre- nor the post-
fusion virion-associated F protein have free thiols. We have
found that overexpression of PDI-like isomerases in cells ex-
pressing both HN and F proteins leads to enhanced cell-cell
fusion, significantly decreased MPB labeling of F protein
(18a), and increased concentrations of the postfusion form of
F protein. Thus, the postfusion form of F protein may not be
a substrate for isomerases.
Taken together, our results show that free thiols are pro-
duced in virion-associated F protein only after binding of virus
to cells (diagramed in Fig. 7). These free thiols appear in F
protein prior to any major conformational changes in the pro-
tein upon fusion activation and are independent of the activa-
tion of F protein by HN protein.
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